Early Access to Medicines Scheme in Oman

About Early Access to Medicines Scheme

UK MHRA's pathway for early access to promising unlicensed medicines.

How Early Access to Medicines Scheme works in Oman

Oman's MoH operates a personal-import pathway; volumes are smaller but the pathway is functional for rare-disease and specialty needs.

Patients in Oman seeking access under Early Access to Medicines Scheme typically follow this flow: a licensed physician in Oman issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.

Documents required in Oman

• Physician prescription and clinical-justification letter.
• Patient identification and consent.
• Country-specific NPP/personal-import form.
• Hospital or clinic attestation where required.

Typical timeline

End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.

Start a request

Start a request under Early Access to Medicines Scheme in Oman